Angusta 25 Mikrogramm Tabletten
Recall
|
Medicines
|
27/06/2022
The marketing authorisation holder informed its customers on June 24, 2022, that due to contamination the mentioned medicinal product is recalled as a precautionary measure. The risk of the contamination has been determined to be low.
Name of the medicinal product | Angusta 25 Mikrogramm Tabletten |
---|---|
Marketing authorisation number(s) | 140316 |
CIP code | 4984654 |
Marketing authorisation holder | Norgine B.V. |
Batch number(s) | Batch, Expiry Date B27754, 30.09.2023 B28186, 31.08.2024 |
Classification of the recall | 2 |
Depth of recall | Pharmacies |
Further inquiry note
Page last modified:
27/06/2022